Search - tctmd.com

Displaying 121 - 140 of 299

Sort: Relevancy | Date

Type A Aortic Dissection Tied to Greater Mortality in Women

News

Type A Aortic Dissection Tied to Greater Mortality in Women

Yael L. Maxwell

June 11, 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

News Conference News EuroPCR 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

May 21, 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year

News Conference News SCAI 2021

Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year

Yael L. Maxwell

May 04, 2021

Primary PCI After TAVI: New Real-world Insights

News Daily News

Primary PCI After TAVI: New Real-world Insights

April 27, 2021

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

Lean Antithrombotic Regimen Recommended After TAVI

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

April 12, 2021

Ross Procedure Shows Durable Benefit at 25 Years

News Daily News

Ross Procedure Shows Durable Benefit at 25 Years

March 26, 2021

PFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE

News Daily News

PFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE

Yael L. Maxwell

March 15, 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

March 08, 2021

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

News Daily News

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Yael L. Maxwell

March 02, 2021

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

December 28, 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 14, 2020

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

October 29, 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

October 17, 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

October 14, 2020

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

Presentation TCT 2020

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

Presenter: Geraud Souteyrand

October 14, 2020

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

Presentation TCT 2020

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Hashrul Rashid

October 14, 2020

TCT 450: Meta-Analysis of Device Related Thrombosis After Left Atrial Appendage Occlusion in Women Versus Men

Presentation TCT 2020

TCT 450: Meta-Analysis of Device Related Thrombosis After Left Atrial Appendage Occlusion in Women Versus Men

Presenter: Yasir Abdul Ghaffar

October 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.